Showing results (71-80 of 99) with videos related to
Sort By:
Pageof 10
European Journal of Medicinal Chemistry|December 13, 2016
Therapeutic evolution of benzimidazole derivatives in the last quinquennial periodWasim Akhtar, Mohemmed Faraz Khan, Garima Verma, et al.Computers in Biology and Medicine|June 8, 2019
Dibenzepinones, dibenzoxepines and benzosuberones based p38α MAP kinase inhibitors: Their pharmacophore modelling, 3D-QSAR and docking studiesMohemmed Faraz Khan, Garima Verma, Perwez Alam, et al.Journal of Biomolecular Structure & Dynamics|December 10, 2019
Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated <i>in silico</i> approachesShweta Sharma, Shubham Srivastava, Apeksha Shrivastava, et al.Archiv Der Pharmazie|December 24, 2019
Identification of novel selective Mtb-DHFR inhibitors as antitubercular agents through structure-based computational techniquesKalicharan Sharma, Nazia Neshat, Shweta Sharma, et al.Bioorganic Chemistry|April 7, 2019
Unveiling novel diphenyl-1H-pyrazole based acrylates tethered to 1,2,3-triazole as promising apoptosis inducing cytotoxic and anti-inflammatory agentsMohemmed Faraz Khan, Tarique Anwer, Afroz Bakht, et al.Acta Poloniae Pharmaceutica|June 9, 2011
Synthesis of some new 2-(substituted-phenyl)-5-(N,N-diphenylaminomethyl)-1,3,4-oxadiazoles: a safer anti-inflammatory and analgesic agentsAditya Kumar Kataria, Suroor Ahmad Khan, Mohammad Mumtaz Alam, et al.European Journal of Medicinal Chemistry|December 30, 2018
Green recipes to quinoline: A reviewLalit Mohan Nainwal, Sharba Tasneem, Wasim Akhtar, et al.Mini Reviews in Medicinal Chemistry|December 23, 2021
Heterocyclic Moieties as HDAC Inhibitors: Role in Cancer TherapeuticsSharba Tasneem, Mohammad Mumtaz Alam, Mohammad Amir, et al.Biochemistry and Biophysics Reports|December 11, 2025
Computational study of chalcone-cyanopyrimidine hybrids as LSD1 inhibitors: Assessing the influence of FAD on binding affinity and inhibitionMd Khalid Saifullah, Amisha Gupta, Darakhshan Parveen, et al.European Journal of Medicinal Chemistry|December 6, 2025
Pharmacophore-guided review of EGFR-targeted anticancer drugs with gefitinib as a referenceMeenu, Khursheed Ahmad Sheikh, M Shaquiquzzaman, et al.Pageof 10